Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 1/20 | 0.36 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.36 |
| ▸ | DAO | P14920 | 1/20 | 0.36 |
| ▸ | NQO1 | P15559 | 1/20 | 0.34 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | FYN | P06241 | 1/20 | 0.31 |
| ▸ | LTA4H | P09960 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | F2 | P00734 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6156485 | 0.96 | CYP4F2 (0.36) | CYP4F2CYP4A11DAONQO1ACHE | |
| SCHEMBL6155258 | 0.91 | ACHE (0.32) | CYP4F2CYP4A11DAOACHEGPBAR1 | |
| SCHEMBL16033984 | 0.84 | NQO1 (0.34) | NQO1MAPTALDH1A1 | |
| SCHEMBL5236102 | 0.83 | NQO1 (0.46) | CYP4F2CYP4A11DAONQO1ACHE | |
| SCHEMBL8751920 | 0.80 | NQO1 (0.46) | NQO1LTA4HALDH1A1 | |
| SCHEMBL6155263 | 0.79 | FFAR1 (0.34) | — | |
| SCHEMBL2938664 | 0.79 | NQO1 (0.46) | CYP4F2CYP4A11NQO1ACHELTA4H | |
| SCHEMBL16956809 | 0.78 | NQO1 (0.41) | CYP4F2CYP4A11DAONQO1ACHE | |
| SCHEMBL24804104 | 0.76 | BPTF (0.33) | ACHEMAPTALDH1A1 | |
| SCHEMBL643648 | 0.75 | FYN (0.40) | CYP4F2CYP4A11DAOACHEGPBAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9566355-B2 | Bacteria-targeted magnetic resonance contrast agents | NORTHWESTERN UNIVERSITY (US) | 2017-02-14 | — | — | US | disclosed |
| US-20140271490-A1 | BACTERIA-TARGETED MAGNETIC RESONANCE CONTRAST AGENTS | NORTHWESTERN UNIVERSITY (US) | 2014-09-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140271490-A1 | BACTERIA-TARGETED MAGNETIC RESONANCE CONTRAST AGENTS | SLC30A6, BAZ1A, BAZ2A | CYP4F2 3626/4885CYP4A11 4877/4885DAO 207/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.